Henry Schein, Inc. Reports Earnings Results for the First Quarter Ended March 30, 2024
May 07, 2024 at 06:00 am EDT
Share
Henry Schein, Inc. reported earnings results for the first quarter ended March 30, 2024. For the first quarter, the company reported sales was USD 3,172 million compared to USD 3,060 million a year ago. Net income was USD 93 million compared to USD 121 million a year ago.
Basic earnings per share from continuing operations was USD 0.72 compared to USD 0.92 a year ago. Diluted earnings per share from continuing operations was USD 0.72 compared to USD 0.91 a year ago.
Henry Schein, Inc. specializes in the distribution of care products and services intended for health professionals (doctors, surgeons, dentists, veterinary laboratories and clinics). Net sales break down by activity as follows:
- distribution of health care products and equipment (93.5%): dental products and equipment (65.4% of net sales; consumable products, laboratory equipment, print materials, implants, anesthetics, etc.) and medical equipment (34.6%; medicines, vaccines, vitamins, surgical material, diagnostic tests, etc.);
- other (6.5%): sale and integration of management software, financial, training, maintenance and equipment repair services.
The United States account for 69.9% of net sales.Henry Schein, Inc. specializes in the distribution of care products and services intended for health professionals (doctors, surgeons, dentists, veterinary laboratories and clinics). Net sales break down by activity as follows:
- distribution of health care products and equipment (93.5%): dental products and equipment (65.4% of net sales; consumable products, laboratory equipment, print materials, implants, anesthetics, etc.) and medical equipment (34.6%; medicines, vaccines, vitamins, surgical material, diagnostic tests, etc.);
- other (6.5%): sale and integration of management software, financial, training, maintenance and equipment repair services.
The United States account for 69.9% of net sales.